Variant report
Variant | nsv968787 |
---|---|
Chromosome Location | chr4:165770780-165787709 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10028712 | chr4:165777000-165777001 | ZNF genes & repeats Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
2 | rs557015284 | chr4:165777019-165777020 | ZNF genes & repeats Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
3 | rs72998131 | chr4:165777020-165777021 | ZNF genes & repeats Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
4 | rs553073124 | chr4:165777022-165777023 | ZNF genes & repeats Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
5 | rs149626562 | chr4:165777026-165777027 | ZNF genes & repeats Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
6 | rs144332745 | chr4:165777031-165777032 | ZNF genes & repeats Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
7 | rs551146424 | chr4:165777032-165777033 | ZNF genes & repeats Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
8 | rs74342048 | chr4:165777036-165777037 | ZNF genes & repeats Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
9 | rs556980314 | chr4:165777045-165777046 | ZNF genes & repeats Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
10 | rs569386156 | chr4:165777109-165777110 | ZNF genes & repeats Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
11 | rs575492830 | chr4:165777133-165777134 | ZNF genes & repeats Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
12 | rs146793970 | chr4:165777168-165777169 | ZNF genes & repeats Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
13 | rs564491754 | chr4:165777171-165777172 | ZNF genes & repeats Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
14 | rs6536871 | chr4:165777179-165777180 | ZNF genes & repeats Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
15 | rs187265603 | chr4:165777216-165777217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs561804803 | chr4:165777219-165777220 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs529448175 | chr4:165777247-165777248 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs75184310 | chr4:165777250-165777251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs113729476 | chr4:165777306-165777307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs563078338 | chr4:165777321-165777322 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs368914691 | chr4:165777324-165777325 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs370394738 | chr4:165777370-165777371 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs527985313 | chr4:165777375-165777376 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs533659720 | chr4:165777444-165777445 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs551911620 | chr4:165777445-165777446 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs144195130 | chr4:165777460-165777461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs528061567 | chr4:165777504-165777505 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs4588417 | chr4:165777512-165777513 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs71618422 | chr4:165777530-165777531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs568117554 | chr4:165777533-165777534 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs374402953 | chr4:165777550-165777551 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs535338012 | chr4:165777569-165777570 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs529050933 | chr4:165777609-165777610 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs6850057 | chr4:165777616-165777617 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs539698264 | chr4:165777617-165777618 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs191762730 | chr4:165777620-165777621 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs151071214 | chr4:165777657-165777658 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs183930245 | chr4:165777686-165777687 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs140989692 | chr4:165777689-165777690 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs150361454 | chr4:165777774-165777775 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs144974740 | chr4:165777784-165777785 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs114289165 | chr4:165777873-165777874 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs533334549 | chr4:165777877-165777878 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs565600729 | chr4:165777929-165777930 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs545696075 | chr4:165777934-165777935 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs560729599 | chr4:165777978-165777979 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs72695868 | chr4:165777992-165777993 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs139837551 | chr4:165778035-165778036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs374013228 | chr4:165778072-165778073 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs568204645 | chr4:165778123-165778124 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 16272173 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20581869 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Myelofibrosis | 22110671 | CNVD |
intellectual deficit | 22127048 | CNVD |
abnormal development | 18461090 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:165777000-165777200 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr4:165777000-165777200 | Flanking Bivalent TSS/Enh | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr4:165777200-165780800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr4:165777600-165778000 | Enhancers | Muscle Satellite Cultured Cells | -- |
5 | chr4:165782200-165787000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
6 | chr4:165786000-165786200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr4:165786200-165787000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr4:165786400-165786600 | Enhancers | H9 Cell Line | embryonic stem cell |
9 | chr4:165786400-165786600 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
10 | chr4:165786600-165787800 | Enhancers | H1 Cell Line | embryonic stem cell |
11 | chr4:165786600-165787800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
12 | chr4:165786600-165788400 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
13 | chr4:165786600-165789400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
14 | chr4:165786600-165796000 | Weak transcription | H9 Cell Line | embryonic stem cell |
15 | chr4:165786800-165787800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
16 | chr4:165787000-165787800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
17 | chr4:165787000-165788800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
18 | chr4:165787000-165789000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
19 | chr4:165787000-165789000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
20 | chr4:165787200-165789400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
21 | chr4:165787400-165789000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
22 | chr4:165787600-165789000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |